Research demonstrates bacterial contamination in pharmacy robots

 

Chicago, Ill., USA (April 4, 2012) – Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

 

During a routine screening in 2010, personnel at Wake Forest Baptist Medical Center in North Carolina discovered Bacillus cereus bacteria in samples dispensed by their machine, the Intellifill IV. "To our knowledge, this is the first published report of a pharmacy robot being contaminated with Bacillus with resultant contamination of intravenous drug product," the report’s authors write.

 

Bacillus is a potentially harmful bacterium that is resistant to many commonly used disinfectants, including alcohol.

 

Personnel discovered the contamination through quality assurance measures recommended by the manufacturer before any patients were harmed by the contaminated drugs. The implications of contaminated intravenous products can be serious, including potentially life-threatening bloodstream infections. While any adverse events were avoided, the investigation into how the machine became contaminated suggests that the current cleaning and maintenance recommendations may need to be strengthened.

 

The investigators traced the contamination to the machine’s washing station and the tubing associated with it. Because this area is not considered a sterile part of the robot, the manufacturer does not specify a cleaning procedure for these parts beyond regular "fogging" with alcohol, using a spray bottle to clean inaccessible parts.

 

"To prevent other users of Intellifill IV from experiencing the same problem, the manufacturer should consider establishing a formal procedure for cleaning and maintaining the washing station, with more detailed recommendations to change the drain tube, the container, and possibly the washing station itself," the authors write. "In addition, it is reasonable to expand existing quality assurance recommendations to include surface testing of the washing station and air sampling in the center of the compartment. Last, using the robot in the pharmacy’s clean room could further decrease the risk of contamination."

 

The findings stress the importance of routine screening of medication prepared by robotic dispensers, which are increasingly used in hospitals. "Quality assurance methods are critical to ensure ongoing patient safety," the authors write.

 

 

  • David Cluck, John C. Williamson, Marty Glasgo, Daniel Diekema, Robert Sherertz, "Bacterial Contamination of an Automated Pharmacy Robot Used for Intravenous Medication Preparation." Infection Control and Hospital Epidemiology 33:5 (May 2012).

 

Published through a partnership between the Society for Healthcare Epidemiology of America and The University of Chicago Press, Infection Control and Hospital Epidemiology provides original, peer-reviewed scientific articles for anyone involved with an infection control or epidemiology program in a hospital or healthcare facility. ICHE is ranked 15 out of 140 journals in its discipline in the latest Journal Citation Reports from Thomson Reuters.

 

SHEA is a professional society representing more than 2,000 physicians and other healthcare professionals around the world with expertise in healthcare epidemiology and infection prevention and control. SHEA’s mission is to prevent and control healthcare-associated infections and advance the field of healthcare epidemiology. The society leads this field by promoting science and research and providing high-quality education and training in epidemiologic methods and prevention strategies. SHEA upholds the value and critical contributions of healthcare epidemiology to improving patient care and healthcare worker safety in all healthcare settings www.shea-online.org

 

 


Society for Healthcare Epidemiology of America, 04.04.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…